BlackRock’s Immunocore IMCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.95M | Sell |
221,379
-4,166
| -2% | -$131K | ﹤0.01% | 3539 |
|
|
2025
Q1 | $6.69M | Sell |
225,545
-47,235
| -17% | -$1.4M | ﹤0.01% | 3474 |
|
|
2024
Q4 | $8.05M | Sell |
272,780
-600,831
| -69% | -$17.7M | ﹤0.01% | 3487 |
|
|
2024
Q3 | $27.2M | Buy |
873,611
+1,818
| +0.2% | +$56.6K | ﹤0.01% | 2796 |
|
|
2024
Q2 | $29.5M | Buy |
871,793
+4,436
| +0.5% | +$150K | ﹤0.01% | 2707 |
|
|
2024
Q1 | $56.4M | Buy |
867,357
+88,326
| +11% | +$5.74M | ﹤0.01% | 2332 |
|
|
2023
Q4 | $53.2M | Buy |
779,031
+19,198
| +3% | +$1.31M | ﹤0.01% | 2390 |
|
|
2023
Q3 | $39.4M | Sell |
759,833
-32,251
| -4% | -$1.67M | ﹤0.01% | 2503 |
|
|
2023
Q2 | $47.5M | Buy |
792,084
+14,158
| +2% | +$849K | ﹤0.01% | 2472 |
|
|
2023
Q1 | $38.5M | Sell |
777,926
-11,069
| -1% | -$547K | ﹤0.01% | 2583 |
|
|
2022
Q4 | $45M | Buy |
788,995
+289,563
| +58% | +$16.5M | ﹤0.01% | 2513 |
|
|
2022
Q3 | $23.4M | Buy |
499,432
+3,250
| +0.7% | +$153K | ﹤0.01% | 2906 |
|
|
2022
Q2 | $18.5M | Hold |
496,182
| – | – | ﹤0.01% | 3065 |
|
|
2022
Q1 | $14.8M | Hold |
496,182
| – | – | ﹤0.01% | 3289 |
|
|
2021
Q4 | $17M | Sell |
496,182
-331,422
| -40% | -$11.3M | ﹤0.01% | 3314 |
|
|
2021
Q3 | $30.7M | Sell |
827,604
-252,322
| -23% | -$9.35M | ﹤0.01% | 2954 |
|
|
2021
Q2 | $42.2M | Sell |
1,079,926
-199
| -0% | -$7.77K | ﹤0.01% | 2770 |
|
|
2021
Q1 | $46M | Buy |
+1,080,125
| New | +$46M | ﹤0.01% | 2633 |
|